The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $58.70

Today's change-0.35 -0.59%
Updated August 4 4:03 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $58.70

Today's change-0.35 -0.59%
Updated August 4 4:03 PM EDT. Delayed by at least 15 minutes.

Reversal following new 20-day high

Merck & Co Inc closed lower Tuesday, dropping (U.S.)$0.35 or 0.59% to (U.S.)$58.70 after setting a new 20-day high. Over the last five days, shares have gained 2.05% and 3.36% year to date. Shares have underperformed the S&P 500 by 5.09% during the last year.

Key company metrics

  • Open(U.S.) $59.44
  • Previous close(U.S.) $59.05
  • High(U.S.) $59.47
  • Low(U.S.) $58.37
  • Bid / Ask-- / --
  • YTD % change+3.36%
  • Volume6,935,771
  • Average volume (10-day)9,641,459
  • Average volume (1-month)8,472,769
  • Average volume (3-month)9,302,681
  • 52-week range(U.S.) $52.49 to (U.S.) $63.62
  • Beta0.47
  • Trailing P/E17.18×
  • P/E 1 year forward16.89×
  • Forward PEG2.48×
  • Indicated annual dividend(U.S.) $1.80
  • Dividend yield3.07%
  • Trailing EPS(U.S.) $3.42
Updated August 4 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+24.39%

Based on its net profit margin of 24.39%, Merck & Co Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.16%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue9,7859,42510,48210,557
Total other revenue--------
Total revenue9,7859,42510,48210,557
Gross profit7,3777,2116,8386,421
Total cost of revenue2,4082,2143,6444,136
Total operating expense8,2397,9909,3069,233
Selling / general / administrative2,4712,3392,7872,797
Research & development1,5841,6722,0811,484
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,7761,765794816
Other operating expenses, total--------
Operating income1,5461,4351,1761,324
Interest income (expense), net non-operating-----165-191
Gain (loss) on sale of assets--------
Other--------
Income before tax8071,38111,8111,490
Income after tax6889587,327842
Income tax, total1194234,484648
Net income6879527,316895
Total adjustments to net income--------
Net income before extra. items6879527,316895
Minority interest-1-6-1153
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6879527,316895
Inc. avail. to common incl. extra. items6879527,316895
Diluted net income6879527,316895
Dilution adjustment------0
Diluted weighted average shares2,8502,8532,8862,911
Diluted EPS excluding extraordinary itemsvalue per share0.240.332.540.31
Dividends per sharevalue per share0.450.450.440.44
Diluted normalized EPSvalue per share0.770.764.410.47